AQR Capital Management - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 78 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$1,938,000
-42.9%
330,073
-55.0%
0.00%
-50.0%
Q4 2017$3,392,000
+90.1%
734,261
+126.0%
0.00%
+100.0%
Q3 2017$1,784,000
+854.0%
324,939
+900.8%
0.00%
Q2 2017$187,00032,4670.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
JBF Capital, Inc. 520,553$161,0000.03%
Kalos Management, Inc. 43,940$13,0000.01%
ACADIAN ASSET MANAGEMENT LLC 1,351,000$419,0000.00%
Quilter Plc 60,546$19,0000.00%
ALBION FINANCIAL GROUP /UT 12,000$4,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$7,0000.00%
MORGAN STANLEY 1,900$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$8,0000.00%
BlackRock Inc. 645,611$200,0000.00%
Bank of New York Mellon Corp 137,500$43,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders